Modeling Land-Cover Types Using Multiple Endmember Spectral Mixture Analysis in a Desert City

Spectral mixture analysis is probably the most commonly used approach among sub-pixel analysis techniques. This method models pixel spectra as a linear combination of spectral signatures from two or more ground components. However, spectral mixture analysis does not account for the absence of one of the surface features or spectral variation within pure materials since it utilizes an invariable set of surface features. Multiple endmember spectral mixture analysis (MESMA), which addresses these issues by allowing endmembers to vary on a per pixel basis, was employed in this study to model Landsat ETM+ reflectance in the Phoenix metropolitan area. Image endmember spectra of vegetation, soils, and impervious surfaces were collected with the use of a fine resolution Quickbird image and the pixel purity index. This study employed 204 (=3x17x4) total four-endmember models for the urban subset and 96 (=6x6x2x4) total five-endmember models for the non-urban subset to identify fractions of soil, impervious surface, vegetation, and shade. The Pearson correlation between the fraction outputs from MESMA and reference data from Quickbird 60 cm resolution data for soil, impervious, and vegetation were 0.8030, 0.8632, and 0.8496 respectively. Results from this study suggest that the MESMA approach is effective in mapping urban land covers in desert cities at sub- pixel level.

Full-Coupled Channel Approach to Doubly Strange ss-Shell Hypernuclei

We describe {\it ab initio} calculations of doubly strange, $S=-2$, $s$-shell hypernuclei ($^4_{\Lambda\Lambda}$H, $^5_{\Lambda\Lambda}$H, $^5_{\Lambda\Lambda}$He and $^6_{\Lambda\Lambda}$He) as a first attempt to explore the few-body problem of the {\it full}-coupled channel scheme for these systems. The wave function includes $\Lambda\Lambda$, $\Lambda\Sigma$, $N\Xi$ and $\Sigma\Sigma$ channels. Minnesota $NN$, D2$^\prime$ $YN$, and simulated $YY$ potentials based on the Nijmegen hard-core model, are used. Bound state solutions of these systems are obtained. We find that a set of phenomenological $B_8B_8$ interactions among the octet baryons in $S=0, -1$ and -2 sectors, which is consistent with all of the available experimental binding energies of $S=0, -1$ and -2 $s$-shell (hyper-)nuclei, can predict a particle stable bound state of $^4_{\Lambda\Lambda}$H. For $^5_{\Lambda\Lambda}$H and $^5_{\Lambda\Lambda}$He, $\Lambda N-\Sigma N$ and $\Xi N-\Lambda\Sigma$ potentials enhance the net $\Lambda\Lambda-N\Xi$ coupling, and a large $\Xi$ probability is obtained even for a weaker $\Lambda\Lambda-N\Xi$ potential.Comment: 4 pages, 1 figur

Prognostic value of troponins in acute coronary syndrome depends upon patient age

Peer reviewedPostprin

Vagus Nerve Stimulation in Refractory Epilepsy: Effects on Pro- and Anti-Inflammatory Cytokines in Peripheral Blood

Objective: The vagus nerve has important immunological functions that may be relevant for its anticonvulsive action. We postulate that this anticonvulsive action is activated by a shift in the immune system resulting in a reduction of neurotoxic and an increase of neuroprotective tryptophan metabolites. Methods: Eleven patients with refractory epilepsy and 11 controls matched for age and gender were included in this study. The primary outcome measure was a 50% seizure reduction. Other variables were pro-inflammatory cytokines IL-6 and TNF-alpha, anti-inflammatory cytokine IL-10, cortisol, and the tryptophan metabolites 3-hydroxykynurenine (3-OH-KYN), kynurenic acid (KYNA), kynurenine, serotonin (5-HT) and 5-hydroxyindol acetic acid (5-HIAA). Blood samples were scheduled during baseline, and in week 28 of add-on treatment. Results: IL-6 levels were higher in the responders than in the control group, and decreased after vagus nerve stimulation (VNS), whereas IL-10 was low and increased after VNS. In nonresponders, VNS resulted in an increase of IL-6 plasma levels and in a decrease of IL-10. Cortisol concentrations are higher in the epilepsy group than in the control group. After VNS, these concentrations decreased. The concentrations of the tryptophan metabolites were lower in the epilepsy group than in the control group. The KYNA ratios are defined as the ratio of neuroprotective KYNA versus neurotoxic 3-OH-KYN and KYNA versus neurotoxic kynurenine: these ratios were lower in epilepsy patients than in controls, and they both moderately increased after VNS. Conclusion: The outcome of this preliminary study indicates that VNS causes a rebalancing of the immune system. This results in: (1) a reduction of neurotoxic and an increase of neuroprotective kynurenine metabolites and (2) in the normalization of cortisol levels. Copyright (C) 2010 S. Karger AG, Base

Hyperonic mixing in five-baryon double-strangeness hypernuclei in a two-channel treatment

Properties of hypernuclei $_{\Lambda \Lambda}^5$H and $_{\Lambda \Lambda }^5$He are studied in a two-channel approach with explicit treatment of coupling of channels ^3\text{Z}+\Lambda+\Lambda and \alpha+\Xi. Diagonal \Lambda\Lambda and coupling \Lambda\Lambda-\Xi N interactions are derived within G-matrix procedure from Nijmegen meson-exchange models. Bond energy \Delta B_{\Lambda\Lambda} in $_{\Lambda \Lambda}^5$He exceeds significantly that in $_{\Lambda \Lambda}^5$H due to the channel coupling. Diagonal \Xi\alpha attraction amplifies the effect, which is sensitive also to \Lambda-core interaction. The difference of the \Delta B_{\Lambda\Lambda} values can be an unambiguous signature of the \Lambda\Lambda-\Xi N coupling in \Lambda\Lambda hypernuclei. However, improved knowledge of the hyperon-nucleus potentials is needed for quantitative extraction of the coupling strength from future data on the \Lambda\Lambda hypernuclear binding energies.Comment: 11 pages with 3 figures; Phys. Rev. C, accepte

A systematic review of tranexamic acid in hip fracture surgery

Aim: To systematically examine and quantify the efficacy and safety of Tranexamic acid in hip fracture surgery.  Methods: A systematic literature search was conducted using Medline, EMBASE, AMED, CiNAHL, and the Cochrane Central Registry of Controlled Trials. Two assessors independently screened search outputs for potentially relevant articles which met the eligibility criteria. The primary outcome measure was requirement of post-operative blood transfusion. Risk of bias assessment was performed using the Cochrane Collaboration’s risk of bias tool for RCT’s and the ROBINS-I tool for observational studies. Meta-analysis was performed to estimate risk ratio (RR), risk difference (RD) and mean difference (MD) values for dichotomous and continuous data outcomes respectively. The interpretation of each outcome was made using the GRADE approach.  Results: Of 102 studies identified, seven met the inclusion criteria including a total of 770 participants (TXA: 341; Control: 429). On meta-analysis, intra-venous TXA resulted in a 46% risk reduction in blood transfusion requirement compared to a placebo/control group (RR:0.54; 95% CI: 0.35 to 0.85; I2: 78%; Inconsistency (Chi2) p=<0.0001; N=750). There was also a significantly higher post-operative haemoglobin for TXA versus placebo/control (MD:0.81; 95% CI: 0.45 to 1.18; I2: 46%; Inconsistency (Chi2) p=0.10; N=638). There was no increased risk of thromboembolic events (RD:0.01; 95% CI: -0.03, 0.05; I2: 68%; Inconsistency (Chi2) p=0.007, N=683).  Conclusion: There is moderate quality evidence that TXA reduces blood transfusion in hip fracture surgery, with low quality evidence suggesting no increased risk of thrombotic events. These findings are consistent with TXA use in other orthopaedic procedures

Stochastic Variational Search for ΛΛ4^{4}_{\Lambda\Lambda}H

A four-body calculation of the $pn\Lambda\Lambda$ bound state, $^{\ 4}_{\Lambda\Lambda}$H, is performed using the stochastic variational method and phenomenological potentials. The$NN$,$\Lambda N$, and$\Lambda\Lambda$potentials are taken from a recent Letter by Filikhin and Gal, PRL{\bf 89}, 172502 (2002). Although their Faddeev-Yakubovsky calculation found no bound-state solution over a wide range of$\Lambda\Lambda$interaction strengths, the present variational calculation gives a bound-state energy, which is clearly lower than the$_\Lambda^3{H}+\Lambda$threshold, even for a weak$\Lambda\Lambda$interaction strength deduced from a recent experimental$B_{\Lambda\Lambda}(^{6}_{\Lambda\Lambda}{He})$value. The binding energies obtained are close to, and slightly larger than, the values obtained from the three-body$d\Lambda\Lambda$ model in the Letter.Comment: Corrected typos, added addtional calculations regarding a truncated to l=0 interaction model, 4 pages, 3 figure

ΛΛ\Lambda\Lambda-ΞN\Xi N-ΣΣ\Sigma\Sigma coupling in ΛΛ 6^{~6}_{\Lambda\Lambda}He with the Nijmegen soft-core potentials

The $\Lambda\Lambda$-$\Xi N$-$\Sigma\Sigma$ coupling in $^{~6}_{\Lambda\Lambda}$He is studied with the [$\alpha$ + $\Lambda$ + $\Lambda$] + [$\alpha$ + $\Xi$ + $N$] + [$\alpha$ + $\Sigma$ + $\Sigma$] model, where the $\alpha$ particle is assumed as a frozen core. We use the Nijmegen soft-core potentials, NSC97e and NSC97f, for the valence baryon-baryon part, and the phenomenological potentials for the $\alpha-B$ parts ($B$=$N$, $\Lambda$, $\Xi$ and $\Sigma$). We find that the calculated $\Delta B_{\Lambda\Lambda}$ of $^{~6}_{\Lambda\Lambda}$He for NSC97e and NSC97f are, respectively, 0.6 and 0.4 MeV in the full coupled-channel calculation, the results of which are about half in comparison with the experimental data, $\Delta B^{exp}_{\Lambda\Lambda}=1.01\pm0.20^{+0.18}_{-0.11}$ MeV. Characteristics of the $S=-2$ sector in the NSC97 potentials are discussed in detail.Comment: 18 pages, 4 figure

In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up.

To determine the optimum duration of follow-up for the assessment of drug efficacy against Plasmodium falciparum malaria, 96 trial arms from randomized controlled trials (RCTs) with follow-up of 28 days or longer that were conducted between 1990 and 2003 were analyzed. These trials enrolled 13,772 patients, and participating patients comprised 23% of all patients enrolled in RCTs over the past 40 years; 61 (64%) trial arms were conducted in areas where the rate of malaria transmission was low, and 58 (50%) trial arms were supported by parasite genotyping to distinguish true recrudescences from reinfections. The median overall failure rate reported was 10% (range, 0 to 47%). The widely used day 14 assessment had a sensitivity of between 0 and 37% in identifying treatment failures and had no predictive value. Assessment at day 28 had a sensitivity of 66% overall (28 to 100% in individual trials) but could be used to predict the true failure rate if either parasite genotyping was performed (r(2) = 0.94) or if the entomological inoculation rate was known. In the assessment of drug efficacy against falciparum malaria, 28 days should be the minimum period of follow-up